General Information
Novo Nordisk BEGIN NN1250-3923
A trial comparing the efficacy and safety of insulin degludec 200 U/mL and insulin degludec 100 U/mL in subjects with type 2 diabetes mellitus
| Protocol | |
|---|---|
| Identifier | NN1250-3923 |
| UID | 944448c3-4261-4309-b2fa-134d42ef96b1 |
| Status | Done - Archived |
| Phase | 3b |
| Category | Diabetes Type 2 / Adult |
| Launch Year | 2011 |
| NCT Number | - |
| Created | 2011-04-06 16:06 |
| Last Updated | 2011-04-06 16:06 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2011-07-28 | No |
| Enrollment Open | 2011-06-01 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2011-06-01 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2012-02-15 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Unger, Jeffrey | JUnger | No |
| Recruiter | - | No | |
| Coordinator | - | No | |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Novo Nordisk |
|---|---|
| Division | Novo Nordisk |
| Team | Novo Nordisk |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
